Vilin Bio Med Limited receives 'No Objection' from NSE regarding Chemgenix Laboratories amalgamation
Vilin Bio Med Limited has announced that it has received an Observation Letter from the National Stock Exchange of India Limited (NSE) granting "No Objection" concerning the proposed Scheme of Amalgamation. The approval was issued by the NSE on August 10, 2026.The scheme involves the amalgamation of M/s Chemgenix Laboratories Private Limited (the Transferor Company) into M/s Vilin Bio Med Limited (the Transferee Company). This development comes in relation to the proposed Scheme involving both companies and their respective Shareholders and Creditors.
While receiving this key regulatory observation, the company stated that the Scheme remains subject to various statutory and regulatory approvals. These required approvals must also be secured from the shareholders and creditors of the involved Companies as necessary.
VILINBIO Stock Price Movement
Today, shares of Vilin Bio Med Limited finished the trading session without movement, settling at ₹41.90 after closing flatly in the market. The stock traded within a range of ₹39.85 and ₹43.95 throughout the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.